Marathon Asset Management (UK)’s CME Group CME Stock Holding History

Marathon Asset Management (UK)’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.5M	Buy	120,131 +14,459	+14%	+$4.29M	1.36%	29
2025 Q4	$28.9M	Sell	105,672 -10,532	-9%	-$2.86M	1.11%	36
2025 Q3	$31.4M	Sell	116,204 -43,143	-27%	-$11.7M	1.16%	34
2025 Q2	$43.9M	Sell	159,347 -2,267	-1%	-$616K	1.41%	28
2025 Q1	$42.9M	Sell	161,614 -18,098	-10%	-$4.46M	1.31%	26
2024 Q4	$42.7M	Buy	179,712 +26,913	+18%	+$6.19M	1.19%	32
2024 Q3	$33.7M	Sell	152,799 -16,200	-10%	-$3.35M	0.93%	40
2024 Q2	$33.2M	Sell	168,999 -11,000	-6%	-$2.27M	1.04%	40
2024 Q1	$38.8M	Sell	179,999 -11,998	-6%	-$2.52M	1.03%	42
2023 Q4	$41.3M	Sell	191,997 -6,098	-3%	-$1.3M	1.16%	34
2023 Q3	$39.7M	Buy	198,095 +38,910	+24%	+$7.73M	1.23%	33
2023 Q2	$29.5M	Buy	+159,185	New	+$29.4M	0.83%	46
2021 Q4	–	Sell	-207,737	Closed	-$40.2M	–	96
2021 Q3	$40.2M	Sell	207,737 -6,070	-3%	-$1.23M	0.49%	67
2021 Q2	$45.5M	Buy	213,807 +10,401	+5%	+$2.2M	0.55%	67
2021 Q1	$41.5M	Sell	203,406 -6,221	-3%	-$1.23M	0.58%	68
2020 Q4	$38.7M	Buy	+209,627	New	+$35.7M	0.54%	74

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marathon Asset Management (UK)'s CME Position: Q1 2026 in Review

Marathon Asset Management (UK) increased its CME Group (CME) stake by 14% in Q1 2026, buying an estimated $4.29M and bringing the position to 120,131 shares worth $35.5M. The position accounts for 1.36% of the portfolio, ranked #29.

Marathon Asset Management (UK) first reported a position in CME in Q4 2020 and has held it in 16 quarters since. The position peaked at $45.5M in Q2 2021. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Marathon Asset Management (UK) held 120,131 shares of CME Group worth $35.5M as of Q1 2026.
Marathon Asset Management (UK) bought 14,459 CME Group shares in Q1 2026, an estimated $4.29M.
CME Group made up 1.36% of Marathon Asset Management (UK)'s portfolio in Q1 2026, its #29 holding.
Marathon Asset Management (UK) first reported a position in CME Group in Q4 2020 and has held it in 16 quarters since.
Marathon Asset Management (UK)'s CME Group position peaked at $45.5M in Q2 2021.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Marathon Asset Management (UK)'s 13F filing for Q1 2026, filed 24 Apr 2026.